TETRAPHASE PHARMACEUTICALS INC Restructuring Charges
TETRAPHASE PHARMACEUTICALS INC reported Restructuring Charges of $2.37 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2020-05-07
- TETRAPHASE PHARMACEUTICALS INC restructuring charges for the quarter ending 2020-03-31 was $2.37M.
- TETRAPHASE PHARMACEUTICALS INC restructuring charges for the quarter ending 2019-12-31 was $0.00.
- TETRAPHASE PHARMACEUTICALS INC restructuring charges for the quarter ending 2019-09-30 was $0.00.
- TETRAPHASE PHARMACEUTICALS INC restructuring charges for the quarter ending 2019-06-30 was $2.40M.
- TETRAPHASE PHARMACEUTICALS INC restructuring charges for fiscal 2019 was $2.37M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | $2.37M 10-Q · filed 2020-05-07 | $2.37M derived: sum of 2 quarters · filed 2020-05-07 | $2.37M derived: sum of 3 quarters · filed 2020-05-07 | $4.77M derived: sum of 4 quarters · filed 2020-05-07 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $2.40M derived: sum of 3 quarters · filed 2020-03-12 | $2.37M 10-K · filed 2020-03-12 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | $2.40M derived: sum of 2 quarters · filed 2019-11-12 | $2.37M 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | $2.40M 10-Q · filed 2019-11-12 | $2.37M 10-Q · filed 2019-08-08 | $2.37M derived: sum of 2 quarters · filed 2020-03-12 | ||
| 2019-03-31 | -$32.00K derived: 10-K 12 month − 3 quarters · filed 2020-03-12 |